Literature DB >> 11113246

Exacerbation of juvenile myoclonic epilepsy with lamotrigine.

A Biraben1, H Allain, J M Scarabin, S Schück, G Edan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113246     DOI: 10.1212/wnl.55.11.1757

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  16 in total

Review 1.  New antiepileptic drugs.

Authors:  C W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  New drugs for the treatment of epilepsy: a practical approach.

Authors:  S Beyenburg; J Bauer; M Reuber
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

3.  Treatment options in juvenile myoclonic epilepsy.

Authors:  Laura Mantoan; Matthew Walker
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

4.  Now we know the drug of first choice--or do we?

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 5.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 6.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 7.  Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.

Authors:  Timothy E Welty
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 8.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Selection criteria for the clinical use of the newer antiepileptic drugs.

Authors:  Charles L P Deckers; P D Knoester; G J de Haan; A Keyser; W O Renier; Y A Hekster
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy.

Authors:  Stéphane Auvin
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.